Dr Sampalis: What I wish I knew before entering optometry
Maria Sampalis, OD, shares what she wishes she knew before entering the field.
Q&A: EyeCon 2022 sneak peek with Dr. Rafieetary
Ahead of this year's annual meeting, Mohammad Rafieetary, OD, FAAO, offers a look at his presentation on diabetic retinal diseases and shares why the event shouldn't be missed.
Supplements slow AMD progression, study data confirm
AREDS2 formula doesn’t contain beta carotene, reducing the risk of lung cancer.
VEW 2022: Analyzing corneal diagnostics A-Z
John D. Gelles, OD, FAAO, FIAOMC, FCLSA, FSLS, FBCLA, shares highlights from his Vision Expo West presentation: "Corneal diagnostics: A-Z."
VEW 2022: Integrating low vision into everyday practice
Alexis Malkin, OD, FAAO, highlights her Vision Expo West 2022 presentation titled, "Expand your practice: how to integrate low vision into everyday patient care and improve outcomes."
VEW 2022: Simple management for keratoconus
John D. Gelles, OD, FAAO, FIAOMC, FCLSA, FSLS, FBCLA, discusses his presentation titled"Keratoconus 1, 2, 3: simple management," during Vision Expo West.
VEW 2022: OSD management: systemic conditions and medications
Jacob R. Lang, OD, FAAO, highlights his Vision Expo West presentation,"An update on systemic conditions and medications you must look out for in OSD management."
VEW 2022: Prescription formulas for pediatric patients
At Vision Expo West 2022, Valerie M. Kattouf, OD, shares her best practices for managing prescription formulas for pediatric patients.
VEW 2022: Neuro-ophthalmology, concussions, and vision
Valerie M. Kattouf, OD, discusses going back to the basics of neuro-ophthalmology + managing vision and visual-motor abnormalities in patients.
VEW 2022: Putting myopia control into practice
Valerie M. Kattouf, OD, shares key highlights and takeaways from her 2022 Vision Expo West presentation titled "Myopia Control."
Heru expands AMD portfolio with new launch
With the launch of dark adaptation, Heru is now the only platform on the AMD market to include contrast sensitivity and dark adaptation exams.
Azura Ophthalmics receives grant for leading CLD clinical candidate
Azura has secured funding to support its 2-stage study evaluating the safety, tolerability, and efficacy of AZR-MD-001, its leading candidate, for patients with contact lens discomfort who show signs of meibomian gland dysfunction.
Phase 2 data finds OCS-01 improves macular thickness, VA in DME patients
OCS-01 is a novel, high concentration, preservative free, topical formulation of dexamethasone that has the potential to be the first topical eye drop and non-invasive treatment for DME.
FDA accepts NDA of NOV03 for DED associated with MGD
Bausch + Lomb and Novaliqu announced that the FDA has accepted its New Drug Application for NOV03, an investigational treatment for dry eye disease associated with meibomian gland dysfunction.
SCOPA: Managing myopia for the future
Ashley Tucker, OD, FAAO, FSLS, Dipl ABO, shares highlights from her discussion titled, "Myopia management: past, present, and future," presented during this year's 115th annual SCOPA meeting.
SCOPA: Troubleshooting and fitting scleral lenses
Ashley Tucker, OD, FAAO, FSLS, Dipl ABO, shares highlights from her presentation on advanced fitting and troubleshooting tips for scleral lenses during the South Carolina Optometric Physicians Association’s annual meeting.
SCOPA: Treating anterior segment disease with amniotic membranes
Ashley Tucker, OD, FAAO, FSLS, Dipl ABO, shares highlights from her presentation on amniotic membrane treatment for anterior segment disease during the South Carolina Optometric Physicians Association’s annual meeting.
SCOPA: Intersection of artificial intelligence and telemedicine
Leo P. Semes, OD, FAAO, highlights his presentation on "Artificial intelligence and telemedicine," presented during the 115th annual SCOPA meeting.
SCOPA 2022: A new look at AMD
Leo P. Semes, OD, FAAO, discusses his presentation on, "A new look at AMD," during the South Carolina Optometric Physicians Association's annual meeting.
SCOPA 2022: When glaucoma isn't glaucoma
Leo P. Semes, OD, FAAO, discusses his presentation on, "When glaucoma isn't glaucoma," during the South Carolina Optometric Physicians Association's annual meeting.
Apellis releases 24-month results of phase 3 studies for GA treatment
Latest data from phase 3 studies finds increased effects over time with intravitreal pegcetacoplan for geographic atrophy secondary to age-related macular degeneration.
Alcon to acquire Aerie Pharma, expanding ophthalmic pharma portfolio
Latest transaction, totaling approximately $770 million, adds key commercial products and clinical/preclinical product candidates in the pipeline.
EyeCare4Kids addresses vision care for local, global communities
EyeCare4Kids founder Joseph Carbone discusses the nonprofit organization's mission to offer services in local communities, as well as its expansion into underserved communities across the globe.
AAO, AAOF announce 2022 award recipients
Results are in for this year's award recipients!
Report: ortho-K expected to surge over next 2 years
Published in Optometry & Visual Sciences, the findings are based on an independent survey featuring feedback from over 500 US eye care professionals.
Study: Neurolenses significantly impact reading speed
Results from a parallel arm study suggest opportunity to expand on visual performance and productivity improvement.
Aerie doses first patient in COMET-3 study for DED treatment
COMET-3 is the second of 3 studies in the AR-15512 Registrational Phase 3 Program, which is slated for completion by 2023.
Newsweek releases 2022 rankings of America’s Best Eye Doctors
After surveying over 10,000 professionals from the nation's eyecare workforce, the results are in for this year's top 175 optometrists.
FDA approves first small aperture IOL for cataract surgery
AcuFocus's IC-8 Apthera IOL features a proprietary small aperture technology that filters out peripheral defocused light and allows only focused light to reach the retina.
Warm starting your dream optometric practice
Adam Ramsey, OD, discusses his recent book titled, "Play Chess Not Checkers: The Practical Guide to Warm Start Your Dream Optometric Practice."
2 Clarke Drive Cranbury, NJ 08512